Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic dietsOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined gut bacteria and their metabolites in children with drug-refractory epilepsy, before and after a ketogenic diet. It also compared patients with healthy children. The design was a cross-sectional study with a before-and-after treatment arm. Fecal microbiota were profiled by 16S rRNA sequencing, and short-chain fatty acids were measured in stool. Patients were reassessed after six months of ketogenic diet treatment.
Who was studied?
The cohort was 12 children with drug-refractory epilepsy and 12 matched healthy controls. The epilepsy group also served as its own comparison before and after diet. All children were treated at a center in Chengdu, China. The ketogenic diet was given for six months, with stool sampled at baseline and after treatment. Responders and non-responders to the diet were also compared.
What were the most important findings?
Children with epilepsy showed higher microbial alpha diversity, plus enrichment of Actinobacteria at the phylum level and Enterococcus, Anaerostipes, Bifidobacterium, Bacteroides, and Blautia at the genus level. After six months of ketogenic diet, eight epilepsy-associated genera reversed: Bifidobacterium, Akkermansia, Enterococcaceae, and Actinomyces decreased, while Subdoligranulum, Dialister, and Alloprevotella increased (P less than 0.05). Fecal short-chain fatty acid content rose after treatment and correlated strongly with gut bacteria. Some taxa were more prevalent in children who responded poorly to the diet.
What are the greatest implications of this study?
The findings suggest gut dysbiosis may contribute to drug-refractory epilepsy and can be partly corrected by a ketogenic diet. Gut bacteria and their short-chain fatty acid output may help mediate the diet's antiseizure effect. The study was small and observational, so it cannot prove causation. Distinct taxa in poor responders hint that microbiota profiling could one day help predict who benefits from the diet, pending larger trials.